Chemours Co.
- CC · NYSE
- Chemicals & Allied Products
- Wilmington, DE
- 5,700 employees
- CIK 0001627223
Updated from SEC filings through
Top things to know
Executives
-
Denise Dignam Chemours President and CEO 8-K, 2026-11-02
-
Shane Hostetter Chief Financial Officer 4, 2026-08-10 - David Will Chief Accounting Officer 4, 2026-08-13
-
Gerardo Familiar President, Advanced Performance Materials 10-K, 2026-02-24 -
Joseph T. Martinko President, Thermal & Specialized Solutions 10-K, 2026-02-24 -
Michael Foley President - Titanium Technologies 10-K, 2026-02-24
What leadership is saying
“Our third-quarter results demonstrate strong year-over-year performance in TT and APM, reflecting pricing execution in TiO 2 and increased demand across Performance Solutions’ high-value AI infrastructure including data center and semiconductor end markets”
Earnings press release (8-K Ex. 99.1), filed November 2, 2026
Chemours Co is a U.S. public company in chemicals & allied products (SIC 2800), headquartered in Wilmington, DE. It trades as CC on NYSE. Revenue was $5.8B in the fiscal year ending December 31, 2025, +0.4% from the year before. It reported about 5,700 employees. Denise Dignam is Chemours President and CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.8B 10-K, 2026-02-24 | $5.8B 10-K, 2026-02-24 | $6.1B 10-K, 2026-02-24 | $6.8B 10-K, 2025-02-18 | $6.3B 10-K, 2024-03-27 |
| Operating income | Not on file | Not on file | Not on file | Not on file | Not on file |
| SG&A | $799M 10-K, 2026-02-24 | $598M 10-K, 2026-02-24 | $1.3B 10-K, 2026-02-24 | $710M 10-K, 2025-02-18 | $592M 10-K, 2024-03-27 |
| Net income | -$386M 10-K, 2026-02-24 | $69.0M 10-K, 2026-02-24 | -$253M 10-K, 2026-02-24 | $578M 10-K, 2025-02-18 | $608M 10-K, 2024-03-27 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| President and Chief Executive Officer | Chemours President and CEO | 8-K, 2026-11-02 |
| Shane Hostetter | Chief Financial Officer | 4, 2026-08-10 |
| David Will Vice President, Chief Accounting Officer at Chemours | Chief Accounting Officer | 4, 2026-08-13 |
| Gerardo Familiar | President, Advanced Performance Materials | 10-K, 2026-02-24 |
| Joseph T. Martinko | President, Thermal & Specialized Solutions | 10-K, 2026-02-24 |
| Michael Foley President, Titanium Technologies Business at Chemours | President - Titanium Technologies | 10-K, 2026-02-24 |
 Kristine Wellman Senior Vice President, General Counsel & Corporate Secretary | Senior Vice President, General Counsel and Corporate Secretary | 10-K, 2026-02-24 |
| Kristine M. Wellman | SVP, GC & Corp. Secretary | 4, 2026-08-04 |
| Mary B. Cranston | Chair of the Board | 10-K, 2026-02-24 |
| Alister Cowan | Director | 10-K, 2026-02-24 |
| Courtney R. Mather | Director | 10-K, 2026-02-24 |
| Erin N. Kane | Director | 10-K, 2026-02-24 |
| George R. Brokaw | Director | 10-K, 2026-02-24 |
| Joseph D. Kava | Director | 10-K, 2026-02-24 |
| Leslie M. Turner | Director | 10-K, 2026-02-24 |
| Livingston Satterthwaite | Director | 10-K, 2026-02-24 |
What Chemours Co does
The Chemours Company (herein referred to as “we”, “us”, or “our”) is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. We deliver customized solutions with a wide range of industrial and specialty chemical products for markets, including refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our principal products include refrigerants, titanium dioxide (“TiO2”) pigment and industrial fluoropolymer resins.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 150.5 million (as of October 27, 2026) | 10-Q, November 5, 2026 |
|---|---|---|
| Public float | $1.7B (as of June 30, 2025) | 10-K/A, November 3, 2026 |
| Reportable segments | 3 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting April 24, 2026 (filed March 10, 2026) | DEF 14A, March 10, 2026 |
| Auditor | PricewaterhouseCoopers LLP (Philadelphia, Pennsylvania) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 12, 2026 | Calderon Gerardo Familiar See Remarks | Buy | 1,935 | $30K | Form 4, August 13, 2026 |
| August 11, 2026 | Denise Dignam Chief Executive Officer | Buy | 3,378 | $51K | Form 4, August 13, 2026 |
| August 7, 2026 | Alister Cowan Director | Buy | 13,000 | $203K | Form 4, August 11, 2026 |
| August 7, 2026 | Michael Robert Foley See Remarks | Buy | 1,934 | $30K | Form 4, August 11, 2026 |
| August 7, 2026 | Joseph T. Martinko See Remarks | Buy | 1,940 | $30K | Form 4, August 11, 2026 |
| August 7, 2026 | Mary B. Cranston Director | Buy | 6,000 | $95K | Form 4, August 11, 2026 |
| August 6, 2026 | Shane Hostetter Chief Financial Officer | Buy | 3,350 | $50K | Form 4, August 10, 2026 |
| August 8, 2025 | Denise Dignam President & CEO | Buy | 4,068 | $49K | Form 4, August 12, 2025 |
Recent 8-K events
- 8-K filed 2026-11-02
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-09-10
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-09-09
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-24
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-04-30
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-03-12
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 8.01 Other events
- 8-K filed 2026-02-26
- Item 8.01 Other events
- 8-K filed 2026-02-19
- Item 2.02 Results of operations and financial condition (earnings release)
Frequently asked questions about Chemours Co
- What does Chemours Co do?
- In its own words, from Item 1 of its 10-K: "The Chemours Company (herein referred to as “we”, “us”, or “our”) is a leading, global provider of performance chemicals that are key inputs in end-products and processes in a variety of industries. We deliver customized solutions with a wide range of industrial and specialty chemical products for markets, including refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our principal products include refrigerants, titanium dioxide (“TiO2”) pigment and industrial fluoropolymer resins."
- What is Chemours Co's revenue?
- $5.8B for the fiscal year ending December 31, 2025, from its 10-K filed February 24, 2026.
- Is Chemours Co profitable?
- Chemours Co reported net income of -$386M for the fiscal year ending December 31, 2025.
- How many employees does Chemours Co have?
- About 5,700 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Chemours Co?
- Denise Dignam, Chemours President and CEO, as named in a 8-K filed November 2, 2026.
- Who is the CFO of Chemours Co?
- Shane Hostetter, Chief Financial Officer, as named in a 4 filed August 10, 2026.
- Where is Chemours Co headquartered?
- Wilmington, DE.
- What is Chemours Co's stock ticker?
- CC on NYSE.
- What industry is Chemours Co in?
- Chemicals & Allied Products, SIC code 2800.
- What is Chemours Co's website?
- chemours.com.
- When does Chemours Co report earnings next?
- February 1, 2027. Source: estimate_8k_pattern.
- Is Chemours Co a public company?
- Yes. Chemours Co files with the SEC under CIK 0001627223 and trades as CC.
- Who audits Chemours Co?
- PricewaterhouseCoopers LLP, Philadelphia, Pennsylvania, as named in its latest annual report (10-K).
- How many shares of Chemours Co are outstanding?
- 150.5 million shares as of October 27, 2026, from its 10-Q filed November 5, 2026.
- What is Chemours Co's public float?
- $1.7B as of June 30, 2025, as reported on the cover of its 10-K/A filed November 3, 2026.
- How many business segments does Chemours Co report?
- 3 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is Chemours Co's annual shareholder meeting?
- April 24, 2026, per its proxy statement (DEF 14A) filed March 10, 2026.
- Have Chemours Co insiders traded stock recently?
- Since August 8, 2025, officers and directors reported 0 open-market sales and 8 purchases worth about $538K on Forms 4 and 5. The most recent: Calderon Gerardo Familiar (See Remarks) bought 1,935 shares on August 12, 2026.